Dietitian-Assisted DASH groceries for Hypertension

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Beth Israel Deaconess Medical Center - Clinical Research Center, Boston, MA
Hypertension
Dietitian-Assisted DASH groceries - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

GoFreshRx is a randomized trial, testing the effects of a home-delivered DASH-patterned grocery intervention on blood pressure in Black adults actively treated for hypertension, residing in Boston area urban food deserts.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Hypertension

Study Objectives

1 Primary · 13 Secondary · Reporting Duration: Measured 3 months after randomization

6 months after randomization
Qualitative Interviews
Month 6
24-hour dietary recall (intervention & observation phases)
24-hour urine potassium (intervention & observation phases)
24-hour urine sodium (intervention & observation phases)
Ambulatory blood pressure monitoring: wake-time systolic and diastolic blood pressure (intervention & observation phases)
Body Mass Index (BMI) (intervention & observation phases)
Hemoglobin A1c (intervention & observation phases)
Lipids (intervention & observation phases)
Seated, office-based, diastolic blood pressure (intervention & observation phases)
Serum creatinine (intervention & observation phases)
Serum potassium (intervention & observation phases)
Month 3
Seated, office-based, systolic blood pressure (intervention phase)
Month 12
Daily intake of fat, fruits, and vegetables (intervention & observation phases)
Grocery shopping and dining habits
Perceived Stress Scale 4 (PSS-4)
Servings of fat, fruits, and vegetables (intervention & observation phases)
Short Form 12 Item Health Survey (SF-12)
Month 6
Seated, office-based, systolic blood pressure (observation phase)

Trial Safety

Safety Progress

1 of 3

Other trials for Hypertension

Trial Design

2 Treatment Groups

Self-directed shopping (referent assignment)
1 of 2
Dietitian-Assisted DASH groceries
1 of 2
Active Control
Experimental Treatment

150 Total Participants · 2 Treatment Groups

Primary Treatment: Dietitian-Assisted DASH groceries · No Placebo Group · N/A

Dietitian-Assisted DASH groceries
Behavioral
Experimental Group · 1 Intervention: Dietitian-Assisted DASH groceries · Intervention Types: Behavioral
Self-directed shopping (referent assignment)
Behavioral
ActiveComparator Group · 1 Intervention: Self-directed shopping · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: measured 3 months after randomization
Closest Location: Beth Israel Deaconess Medical Center - Clinical Research Center · Boston, MA
Photo of Boston 1Photo of Boston 2Photo of Boston 3
N/AFirst Recorded Clinical Trial
2 TrialsResearching Hypertension
0 CompletedClinical Trials

Who is running the clinical trial?

National Institute on Minority Health and Health Disparities (NIMHD)NIH
264 Previous Clinical Trials
448,779 Total Patients Enrolled
15 Trials studying Hypertension
10,306 Patients Enrolled for Hypertension
Beth Israel Deaconess Medical CenterLead Sponsor
767 Previous Clinical Trials
848,967 Total Patients Enrolled
6 Trials studying Hypertension
603 Patients Enrolled for Hypertension
Stephen P Juraschek, MD, PhDPrincipal InvestigatorBeth Israel Deaconess Medical Center
1 Previous Clinical Trials
150 Total Patients Enrolled
1 Trials studying Hypertension
150 Patients Enrolled for Hypertension

Eligibility Criteria

Age 18+ · All Participants · 10 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are Black or African American.
You are able to receive home-delivered groceries or pick them up at a convenient location and willing to eat only the groceries provided over a 12-week period.
You have access to refrigeration, cooking appliances, and Wi-Fi/cellular service.
You have access to a mobile device or computer to be able to conduct grocery orders via video conference or by phone.
You have a serum potassium level of 5.0 mmol/L or less.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.